Insulet Corp. Stock
Price
Target price
€263.40
€263.40
-0.340%
-0.9
-0.340%
€309.45
03.10.25 / Tradegate
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insulet Corp. Stock
The price for the Insulet Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.900 (-0.340%).
With 32 Buy predictions and not a single Sell prediction Insulet Corp. is an absolute favorite of our community.
As a result the target price of 309 € shows a slightly positive potential of 17.31% compared to the current price of 263.4 € for Insulet Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insulet Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insulet Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | -0.340% | -3.055% | -10.591% | 25.190% | 4.648% | 12.492% | 33.165% |
| Bio-Rad Labs Inc. A | 1.990% | 9.126% | 0.982% | -17.118% | -18.147% | -39.832% | -42.095% |
| Neogen Corp. | 0.000% | 7.359% | 0.813% | -64.823% | -58.667% | - | - |
| Haemonetics Corp. | - | 0.995% | -9.375% | -42.000% | -46.225% | -45.503% | -44.762% |
Comments
Insulet (NASDAQ:PODD) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $399.00 to $375.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (NASDAQ:PODD) had its price target raised by analysts at Piper Sandler from $320.00 to $360.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (NASDAQ:PODD) had its price target raised by analysts at JPMorgan Chase & Co. from $340.00 to $415.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
News
Insulet (PODD) Q2 Revenue Jumps 33%
Insulet (NASDAQ:PODD), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong
3 Medical Technology Stocks Outperforming in 2025
As the broader market stages a sharp rebound from its April lows, several sectors, industries, and stocks have quietly emerged as leaders. Among them, the medical technology industry, known for
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer
[content-module:CompanyOverview|NASDAQ:PODD]
Insulet Corporation’s (NASDAQ: PODD) recent outperformance has caught investors' attention and has earned it a designation as a top performer on the